WHO Director-General commended Abu Dhabi Stem Cells Centre on COVID-19 treatments and ADSCC also specialises in developing pioneering technology methods for targeted stem cell therapies that rapidly detect, identify, and count specific cells
ADSCC’s research was referenced in the latest edition of the WHO Therapeutics and COVID-19 Living Guideline issued on 7th December, which notes the most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19.
ADSCC was also commended for contributing to the national testing and vaccination programme as the centre recorded over 14.5 million PCR tests to date
ADSCC recently succeeded in its first experiment to locally manufacture CAR T-Cells in a laboratory and is close to starting clinical trials to prove the safety and effectiveness of CAR T-Cell therapy in treating hematologic cancers.
I take care of the center's efforts and we look forward to further success.
Comments
Post a Comment